A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.

NCT00440063 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: epoetin beta [NeoRecormon]

Sponsor

Hoffmann-La Roche